表紙
市場調査レポート

心調律管理装置の世界市場

Cardiac Rhythm Management Device Markets

発行 Kalorama Information 商品コード 328710
出版日 ページ情報 英文 200 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
心調律管理装置の世界市場 Cardiac Rhythm Management Device Markets
出版日: 2015年05月01日 ページ情報: 英文 200 Pages
概要

心血管疾患は先進国において最も一般的な死亡原因であり、心血管疾患は国際的問題として世界的に注目されています。

当レポートでは、心調律管理装置市場について調査し、市場の現状と2020年までの予測、地域別動向、および主要企業のプロファイルをまとめています。

エグゼクティブサマリー

イントロダクション

  • 概要
  • 鬱血性心不全
  • 心不全の種類
  • 鬱血性心不全の治療
  • 血液動態反応に基づく治療
  • 鬱血性心不全につながる症状
  • 世界の心血管疾患
    • 米国
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
  • 人口統計
  • 世界人口動向
  • 高齢化
  • 心血管疾患と心調律管理装置
  • 技術的進歩
  • 埋め込み医療機器

心臓除細動装置市場

  • 概要
  • 体外除細動器
  • AED
  • ウェアラブル除細動器
  • 埋め込み除細動器
  • 心臓再同期療法:除細動器
  • 市場サマリー
  • 市場参入企業

心臓ペースメーカー装置市場

  • 概要
  • 体外ペースメーカー
  • 埋め込みペースメーカー
  • 心臓再同期療法:ペースメーカー
  • 市場サマリー
  • 市場参入企業

世界市場サマリー

  • 世界市場の規模と予測
  • 製品セグメント別市場
  • 考察

世界市場:国別分析

  • 国別市場サマリー

企業プロファイル

  • Biotronik
  • Boston Scientific
  • Cardiac Science Corp
  • MEDTRONIC
  • 日本光電工業株式会社
  • Philips Healthcare
  • Schiller
  • Sorin
  • St. Jude Medical
  • ZOLL Medical

企業ディレクトリ

図表

目次
Product Code: KLI5523237

As cardiovascular disease is the most common cause of mortality in the developed world, it is natural that a great deal of emphasis should be placed on devices used to treat advanced cardiovascular disease, particularly arrhythmias and congestive heart failure.

This report, Cardiac Rhythm Device Markets, includes cardiac rhythm management devices with both external and internal applications. Major segments include defibrillators: electrical devices that deliver therapeutic levels of energy to the heart muscle for the treatment of ventricular defibrillation. pacemakers: small electrical generators that control a patient's heartbeat.

These cardiac rhythm devices are broken into further segments with market sizing and forecasts to 2019:

  • Sales of Cardiac Defibrillator by Type (External, Implantable)
  • Sales of External Defibrillators by Product Type, (AEDs, Professional/Manual Defibrillators)
  • Sales of Implantable Cardiac Defibrillators by Product Type, 2015 (Standard ICD, CRT-D)
  • Sales of Cardiac Pacemaker by External and Implantable Types
  • Sales of Implantable Cardiac Pacemakers by Product Type (Standard ICP, CRT-P)

as one cardiovascular condition very often influences the onset of others (e.g., hypertension resulting in stroke or congestive heart failure or atherosclerosis resulting in angina or myocardial infarction) there is urgency to discovering the root causes of cardiovascular disease in the hopes of not only treating the initial conditions, but also preventing them.

Cardiovascular disease is an international problem and the focus of major world healthcare systems. The report also provides overall rhythm management device market size and forecast (2014-2019) for each of the following countries:

  • United States
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Brazil
  • China
  • Japan
  • Australia

Major participants are discussed in the report, including:

  • Biotronik
  • Boston Scientific
  • Cardiac Science Corporation
  • Medtronic, Inc.
  • Nihon Kohden
  • Philips Healthcare
  • Schiller AG
  • Sorin Group
  • St. Jude Medical
  • ZOLL Medical Corporation

Primary sources include telephone interviews and email correspondence with more than 100 key industry officials, consultants, health care providers, and government personnel on the topic of cardiac rhythm management. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with company representatives included marketing directors, division managers, and product representatives. Secondary sources such as company literature, databases, investment reports, and medical, information technology and business journals were used to complement primary information.

The base year for the report is 2015, with forecasts provided for each year through 2020. The market was evaluated via a combination of disease prevalence trends, population trends, device innovations, federal and industry standards and regulations. Both primary and secondary sources were consulted in developing market estimates.

Table of Contents

EXECUTIVE SUMMARY

  • Introduction
  • Scope and Methodology
  • Size and Growth of the Market
  • Leading Competitors

INTRODUCTION

  • Overview
  • Congestive Heart Failure
  • Types of Heart Failure
  • Left Ventricular (LV) Failure
  • Right Ventricular (RV) Failure
  • Systolic Dysfunction
  • Diastolic Dysfunction
  • High Output Failure
  • Theories of Congestive Heart Failure
  • Hemodynamic Response Theory
  • Neurohormonal Response Theory
  • Renal Response Theory
  • Conditions Leading to Congestive Heart Failure
  • Hypertension: The Silent Killer
  • Arteriosclerosis/Atherosclerosis: A Path to Ischemic Heart Disease
  • Myocardial Infarction
  • Atrial Fibrillation
  • Cardiomyopathy
  • Alcoholism and Cardiovascular Disease
  • Diabetes and Cardiovascular Disease
  • Obesity and Cardiovascular Disease
  • Chronic Anemia and Cardiovascular Disease
  • Cancer Treatment and Cardiovascular Disease
  • Chronic Illicit Drug Use and Cardiovascular Disease
  • Chronic Renal Failure and Cardiovascular Disease
  • Summary
  • Cardiovascular Disease around the World
  • United States
  • Europe
  • Asia Pacific
  • Latin America
  • Population Statistics
  • Global Population Trends
  • Aging of the Population
  • Cardiovascular Diseases and Cardiac Rhythm Management Devices
  • Technology Advancements
  • Implantable Medical Devices
  • Magnetic Resonance Imaging (MRI)-Compatible Pacemakers
  • Barostim Neo Legacy
  • Leadless Pacemakers
  • Subcutaneous Devices
  • Impella RP System
  • CardioMEMS HF System

CARDIAC DEFIBRILLATOR DEVICE MARKET

  • Overview
  • External Defibrillators
  • Automated External Defibrillators (AEDs)
  • Wearable Defibrillators
  • Implantable Cardioverter Defibrillators
  • Cardiac Resynchronization Therapy - Defibrillator
  • Market Summary
  • External Defibrillator Market Summary
  • Implantable Cardiac Defibrillator Market Summary
  • Leading Market Participants
  • Biotronik
  • Boston Scientific
  • Defibtech
  • Fukuda Denshi Co.
  • Medtronic
  • Mindray
  • Nihon Kohden
  • Philips Medical Systems
  • Physio-Control
  • Schiller AG
  • Sorin Group
  • St. Jude Medical
  • ZOLL Medical

CARDIAC PACEMAKER DEVICE MARKET

  • Overview
  • External Pacemakers
  • Implantable Cardiac Pacemakers
  • Cardiac Resynchronization Therapy - Pacemaker
  • Market Summary
  • External Pacemaker Market Summary
  • Implantable Pacemaker Market Summary
  • Market Participants
  • Biotronik
  • Boston Scientific
  • Medtronic
  • Sorin Group
  • St. Jude Medical

GLOBAL MARKET SUMMARY

  • Total Global Market Size and Forecast
  • Global Markets by Product Segment
  • Market Considerations
  • Consideration One
  • Consideration Two
  • Consideration Three

GLOBAL MARKETS: COUNTRY ANALYSIS

COUNTRY MARKET SUMMARY

  • United States Market Analysis
  • Demographic Trends
  • U.S. Population over 65
  • U.S. Cardiac Rhythm Management Market Size and Forecast
  • Japan Market Analysis
  • Demographic Trends
  • Japan Population over 65
  • Japan Cardiac Rhythm Management Market Size and Forecast
  • Germany Market Analysis
  • Demographic Trends
  • Germany Population over 65
  • Germany Cardiac Rhythm Management Market Size and Forecast
  • Italy Market Analysis
  • Demographic Trends
  • Italy Population over 65
  • Italy Cardiac Rhythm Management Market Size and Forecast
  • France Market Analysis
  • Demographic Trends
  • France Population over 65
  • France Cardiac Rhythm Management Market Size and Forecast
  • United Kingdom Market Analysis
  • Demographic Trends
  • United Kingdom Population over 65
  • United Kingdom Cardiac Rhythm Management Market Size and Forecast
  • China Market Analysis
  • Demographic Trends
  • China Population over 65
  • China Cardiac Rhythm Management Market Size and Forecast
  • Spain Market Analysis
  • Demographic Trends
  • Spain Population over 65
  • Spain Cardiac Rhythm Management Market Size and Forecast
  • Brazil Market Analysis
  • Demographic Trends
  • Brazil Population over 65
  • Brazil Cardiac Rhythm Management Market Size and Forecast
  • Canada Market Analysis
  • Demographic Trends
  • Canada Population over 65
  • Canada Cardiac Rhythm Management Market Size and Forecast
  • Australia Market Analysis
  • Demographic Trends
  • Australia Population over 65
  • Australia Cardiac Rhythm Management Market Size and Forecast

CORPORATE PROFILES

  • Introduction
  • Patents
  • Profiles
  • Biotronik
  • Company Overview
  • Patents
  • Performance Review
  • Boston Scientific
  • Company Overview
  • Patents
  • Performance Review
  • Cardiac Science Corp
  • Company Overview
  • Patents
  • MEDTRONIC
  • Company Overview
  • Patents
  • Performance Review
  • Nihon Kohden
  • Company Overview
  • Patents
  • Performance Review
  • Philips Healthcare
  • Company Overview
  • Patents
  • Performance Review
  • Schiller
  • Company Overview
  • Patents
  • Sorin
  • Company Overview
  • Patents
  • Performance Review
  • St. Jude Medical
  • Company Overview
  • Patents
  • Performance Review
  • ZOLL Medical
  • Company Overview
  • Patents

COMPANY DIRECTORY

LIST OF EXHIBITS

EXECUTIVE SUMMARY

  • Table 1-1 The Global Market for Cardiac Rhythm Management Devices 2010-2020
  • Figure 1-1 The Global Market for Cardiac Rhythm Management Devices 2010-2020

INTRODUCTION

  • Table 2-1 Common Contributors to Congestive Heart Failure
  • Table 2-2 World Cardiovascular Disease Prevalence/Incidence
  • Table 2-3 U.S. Prevalence/Incidence and Mortality of Selected Cardiovascular Conditions and Diseases
  • Table 2-4 Global Population and Average Annual Change, 2005 - 2050
  • Figure 2-1 The Global Population, 2005-2050
  • Table 2-5 Global Population Trends Age 65+, 2000-2050
  • Figure 2-2 Global Population Trends Age 65+, 2000-2050

CARDIAC DEFIBRILLATOR DEVICE MARKET

  • Table 3-1 Professional External Defibrillator Devices
  • Table 3-1 (continued) Professional External Defibrillator Devices
  • Table 3-2 Automated External Defibrillator (AED) Devices
  • Table 3-2 (continued) Automated External Defibrillator (AED) Devices
  • Table 3-3 Wearable External Defibrillator Devices
  • Table 3-4 Implantable Cardioverter Defibrillators (ICD) Devices
  • Table 3-4 (continued) Implantable Cardioverter Defibrillators (ICD) Devices
  • Table 3-5 Cardiac Resynchronization Therapy Defibrillator Devices
  • Table 3-5 (continued) Cardiac Resynchronization Therapy Defibrillator Devices
  • Table 3-6 The Global Cardiac Defibrillator Device Market 2010-2020
  • Figure 3-1 The Global Cardiac Defibrillator Device Market 2010-2020
  • Figure 3-2 Distribution of Sales by Cardiac Defibrillator General Product Type, 2015
  • Figure 3-4 The Global External Defibrillator Market 2010-2020
  • Figure 3-5 Distribution of Sales by External Cardiac Defibrillator Product Type, 2015
  • Figure 3-6 The Global Implantable Defibrillator Market 2010-2020
  • Figure 3-7 Distribution of Sales by Implantable Cardiac-Defibrillators by Product Type, 2015
  • Table 3-7 Competitor Analysis, Global Cardiac Defibrillator Device Market, 2015
  • Figure 3-8 Competitor Analysis, Global Cardiac Defibrillator Device Market, 2015

CARDIAC PACEMAKER DEVICE MARKET

  • Table 4-1 Implantable Cardiac Pacemaker Devices
  • Table 4-1 (continued) Implantable Cardiac Pacemaker Devices
  • Table 4-2 Cardiac Resynchronization Therapy Pacemaker Devices
  • Table 4-3 The Global Cardiac Pacemaker Device Market 2010-2020
  • Figure 4-1 The Global Cardiac Pacemaker Device Market 2010-2020
  • Figure 4-2 Distribution of Sales by Cardiac Pacemaker General Product Type, 2015
  • Figure 4-3 The Global External Pacemaker Market 2010-2020
  • Figure 4-4 The Global Implantable Pacemaker Market 2010-2020
  • Figure 4-5 Distribution of Sales by Implantable Cardiac Pacemakers by Product Type, 2015
  • Table 4-4 Competitor Analysis, Global Cardiac Pacemaker Device Market, 2015
  • Figure 4-6 Competitor Analysis, Global Cardiac Pacemaker Device Market, 2015

GLOBAL MARKET SUMMARY

  • Table 5-1 The Global Market for Cardiac Rhythm Management Devices 2010-2020
  • Figure 5-1 The Global Market for Cardiac Rhythm Management Devices 2010-2020
  • Table 5-2 The Global Cardiac Rhythm Management Market by Major Product Segment 2010-2020
  • Figure 5-2 The Global Cardiac Rhythm Management Market by Major Product Segment 2010-2020

GLOBAL MARKETS: COUNTRY ANALYSIS

  • Table 6-1 The Global Cardiac Rhythm Management Market by Country, Estimated 2015
  • Figure 6-2 Global Cardiac Rhythm Management Market, Distribution of Sales by Country, 2015101
  • Table 6-2 The U.S. Population, 1980-2050
  • Figure 6-3 The U.S. Population, 1980-2050
  • Table 6-3 Percent U.S. Population Over Age 65 by Year, 2000-2050
  • Figure 6-4 United States Population Trend Age 65+, 2000-2050
  • Figure 6-5 United States Market for Cardiac Rhythm Management Devices 2010-2020
  • Table 6-4 Japan Population, 1980-2050
  • Figure 6-6 Japan Population, 1980-2050
  • Table 6-5 Percent Japan Population Over Age 65 by Year, 2000-2050
  • Figure 6-7 Japan Population Trend Age 65+, 2000-2050
  • Figure 6-8 Japan Market for Cardiac Rhythm Management Devices 2010-2020
  • Table 6-6 The Germany Population, 1980-2050
  • Figure 6-9 Germany Population, 1980-2050
  • Table 6-7 Percent Germany Population Over Age 65 by Year, 2000-2050
  • Figure 6-10 Germany Population Trend Age 65+, 2000-2050
  • Figure 6-11 Germany Market for Cardiac Rhythm Management Devices 2010-2020
  • Table 6-8 Italy Population, 1980-2050
  • Figure 6-12 Italy Population, 1980-2050
  • Table 6-9 Percent Italy Population Over Age 65 by Year, 2000-2050
  • Figure 6-13 Italy Population Trend Age 65+, 2000-2050
  • Figure 6-14 Italy Market for Cardiac Rhythm Management Devices 2010-2020
  • Table 6-10 France Population, 1980-2050
  • Figure 6-15 France Population, 1980-2050
  • Table 6-11 Percent France Population Over Age 65 by Year, 2000-2050
  • Figure 6-16 France Population Trend Age 65+, 2000-2050
  • Figure 6-17 France Market for Cardiac Rhythm Management Devices 2010-2020
  • Table 6-12 United Kingdom Population, 1980-2050
  • Figure 6-18 United Kingdom Population, 1980-2050
  • Table 6-13 Percent United Kingdom Population Over Age 65 by Year, 2000-2050
  • Figure 6-19 United Kingdom Population Trend Age 65+, 2000-2050
  • Figure 6-20 United Kingdom Market for Cardiac Rhythm Management Devices 2010-2020
  • Table 6-14 China Population, 1980-2050
  • Figure 6-21 China Population, 1980-2050
  • Table 6-15 Percent China Population Over Age 65 by Year, 2000-2050
  • Figure 6-22 China Population Trend Age 65+, 2000-2050
  • Figure 6-23 China Market for Cardiac Rhythm Management Devices 2010-2020
  • Table 6-16 Spain Population, 1980-2050
  • Figure 6-24 Spain Population, 1980-2050
  • Table 6-17 Percent Spain Population Over Age 65 by Year, 2000-2050
  • Figure 6-25 Spain Population Trend Age 65+, 2000-2050
  • Figure 6-26 Spain Market for Cardiac Rhythm Management Devices 2010-2020
  • Table 6-18 Brazil Population, 1980-2050
  • Figure 6-27 Brazil Population, 1980-2050
  • Table 6-19 Percent Brazil Population Over Age 65 by Year, 2000-2050
  • Figure 6-28 Brazil Population Trend Age 65+, 2000-2050
  • Figure 6-29 Brazil Market for Cardiac Rhythm Management Devices 2010-2020
  • Table 6-20 Canada Population, 1980-2050
  • Figure 6-30 Canada Population, 1980-2050
  • Table 6-21 Percent Canada Population Over Age 65 by Year, 2000-2050
  • Figure 6-31 Canada Population Trend Age 65+, 2000-2050
  • Figure 6-32 Canada Market for Cardiac Rhythm Management Devices 2010-2020
  • Table 6-22 Australia Population, 1980-2050
  • Figure 6-33 Australia Population, 1980-2050
  • Table 6-23 Percent Australia Population Over Age 65 by Year, 2000-2050
  • Figure 6-34 Australia Population Trend Age 65+, 2000-2050
  • Figure 6-35 Australia Market for Cardiac Rhythm Management Devices 2010-2020

CORPORATE PROFILES

  • Figure 7-1 Utility Patents by Country of Origin
  • Figure 7-1 Boston Scientific's Financial Performance, 2011-2014
  • Figure 7-2 Medtronic's Financial Performance, 2011-2014
  • Figure 7-3 Nihon Kohden's Financial Performance, 2011-2014(e)
  • Figure 7-4 Royal Philips' Financial Performance, 2011-2014
  • Figure 7-5 Sorin Group' Financial Performance, 2011-2014
  • Figure 7-6 St. Jude's Financial Performance, 2011-2014

COMPANY DIRECTORY

Back to Top